Clinical features and risk factors of lung cancer patients complicated with venous thromboembolism

Na-na HU,Lei-jie CAO,Huai-ling XIA,Sheng-tang GAO,Da-qing XIA,Zi-mei JI,Zai-jun LENG

DOI: https://doi.org/10.3969/j.issn.1009-6663.2016.09.034

2016-01-01

Abstract:Objective To investigate the clinical features and risk factors of lung cancer patients complicat -ed with venous thromboembolism ( VTE) .Methods The clinical date of 33 cases of lung cancer complicated with VTE were compared with another 66 cases of lung cancer patients without VTE during the same period , including the general conditions, laboratory tests, pathological type, tumor differentiation, clinical stage, gene detection and treat-ment .Results Patients with ZPS≥2 and an increase in D-dimer level in the VTE group were significantly more than patients without VTE , and the levels of serum total protein and albumin were lower in the VTE group than in patients without VTE.In this two groups, the main pathological type was adenocarcinoma , and most of them were stage Ⅳand poorly differentiated .The proportion of adenocarcinoma and patients who received EGFR-TKI treatment in the VTE group were higher than that in patients without VTE .The incidence of VTE was 6.06%, 33.33%, 48.48%, 57.58%and 69.70%before and 3,6 and 12 months after confirmed diagnosis , respectively.The cumulative inci-dence of VTE was 31.82%, 81.82%, 86.36% and 90.91% before and 3, 6 and 12 months after chemotherapy , respectively.Conclusion The risk factors of VTE in patients with lung cancer include ZPS≥2, serum total protein and albumin reduced , D-dimer increased and pathological types of adenocarcinoma , and EGFR-TKI treatment , and most VTE occurred within 3 to 6 months after confirmed diagnosis of lung cancer and the treatment of chemotherapy .